Antibiotics are becoming increasingly ineffective as pathogens become resistant. We face a severe shortage of antimicrobial drugs that work because classical discovery of novel antibiotics that circumvent resistances has become exceedingly difficult. At SpheroBiotics, we have devised a technology platform that re-invents antibiotic discovery from nature’s microbial communities. This will help the pharmaceutical industry to refill their antibiotic drug pipelines to cure deadly infections.